Targeted inhibition of MEK1 by cobimetinib leads to differentiation and apoptosis in neuroblastoma cells.

J Exp Clin Cancer Res · 2015 · PMC4575431 · PMID 26384788

Europe PMC DOI

hedged sentence

0.0100

closest p · 0.2× alpha

0.0100

boldest claim

The sentences

highly significantp < 0.01actually significant

The results are considered statistically significant versus the untreated cells, with a probability level of p < 0.05 (*), or statistically highly significant with a probability level of p < 0.01 (**).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.